Use of thymosin alpha 1 for the treatment of immunological...

Details Use of thymosin alpha 1 for the treatment of immunological... Use of thymosin alpha 1 for the treatment of immunological...

A - Human Necessities

61

K

A61K 38/22 (2006.01)

Patent

CA 2648889

It is described the use of thymosin alpha 1 for preparing a medicament useful for the prevention or treatment of graft-versus-host disease or graft rejection reactions in organ transplantation, in a mammal subject, in which the cells, tissues or organs for transplant is selected from the group comprising: stem cells, hematopoietic stem cells, bone marrow, heart, liver, kidney, lung, pancreas, small intestine, cornea or skin.

La présente invention concerne l'utilisation de thymosine alpha 1 pour préparer un médicament utilisable pour la prévention ou le traitement de la réaction du greffon contre l'hôte ou des réactions de rejet du greffon lors d'une transplantation d'organe chez un sujet mammalien, les cellules, les tissus ou les organes à transplanter étant choisis dans le groupe qui comprend les cellules souches, les cellules souches hématopoïétiques, la moelle osseuse, le cAEur, le foie, le rein, le poumon, le pancréas, l'intestin grêle, la cornée et la peau.

Affiliated with

Also associated with

Rating

Use of thymosin alpha 1 for the treatment of immunological... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of thymosin alpha 1 for the treatment of immunological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thymosin alpha 1 for the treatment of immunological... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1725890